We are pleased to announce that Katy Van Pelt has joined the firm as Counsel in the Regulatory, Food & Drug, Health Care, and Life Sciences practice groups.
Ms. Van Pelt provides advice on a range of regulatory issues relevant to manufacturers of prescription drugs, medical devices, in vitro diagnostic products, analyte-specific reagents, laboratory developed tests, infant formula, and food.
Her practice includes counseling on issues relating to advertising and promotion, where she works with clients to maximize the effectiveness of compliant advertising campaigns in all forms of media. Ms. Van Pelt also advises manufacturers on the creation of and boundaries associated with non-promotional communications, including for products in development, and on the use of scientific exchange, interactions with health care professionals, scientific and educational grants and health economic data. In addition, Ms. Van Pelt advises on issues related to clinical trials, pharmacovigilance, adverse event and MDR reporting, risk mitigation, product packaging, and quality issues such as 483 responses, field alerts and product recalls.
Ms. Van Pelt earned her J.D. from The College of William and Mary School of Law. Prior to joining Potomac Law, she worked as in-house counsel at Abbott Laboratories and in private practice at Sidley Austin, LLP and Wiley Rein, LLP.